(NewsNation) — The commissioner of the Food and Drug Administration says the agency will not overlook anything in developing new guidelines for COVID-19 vaccines. “A lot of people report vaccine ...
WASHINGTON, DC - DECEMBER 06: Dr. Vinay Prasad currently directs the FDA's Center for Biologics Evaluation and Research. (Photo by Marvin Joseph/The Washington Post via Getty Images) Dr. Vinay Prasad, ...
Eli Lilly’s deals add late- and early-stage vaccine assets: a potentially better-tolerated shingles candidate, bacterial ...
A study finds that the antiviral drug is safe to prescribe in children with COVID-19 who are at least 6 years old.
The Department of Health and Human Services is winding down emergency authorizations related to Covid-19 for drugs and biological products, as well as medical devices, after concl ...
The commissioner of the US Food and Drug Administration assured physicians and other healthcare providers that vaccine and therapeutics approvals for the COVID-19 pandemic will be “based on good ...
On March 11, the FDA launched the Adverse Event Monitoring System (AEMS), consolidating several fragmented reporting databases into a single real-time public dashboard with artificial intelligence ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results